Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Disease overview

Viral

Lassa

拉沙热

Evidence-backed informationEN 5/7 applicable sections · ZH 5/7 applicable sectionsUpdated Sep 3, 2026

Lassa fever is a viral haemorrhagic fever caused by the Lassa virus, a member of the Arenaviridae family, and is endemic in rodent populations across several West African countries including Sierra Leone and Nigeria [1][2]. The disease is of growing public-health concern because of increasingly frequent outbreaks, the potential geographic expansion of its Mastomys natalensis reservoir, the emergence of novel viral strains in densely populated regions, and the risk of importation into non-endemic areas [2]. As of the time of the reviewed evidence, no vaccine has been approved for human use, and fundamental gaps in immunology, epidemiology, ecology, and pathogenesis persist [2].

Read the full clinical and epidemiological profile6
Definition

Lassa fever, also known as Lassa haemorrhagic fever, is a viral haemorrhagic fever caused by the Lassa virus [1][2]. The Lassa virus is a member of the Arenaviridae family and was first described in 1969 from a case identified in the town of Lassa, in Borno State, Nigeria [1].

Clinical features

Many individuals infected with Lassa virus do not develop symptoms, and when illness occurs it typically begins with fever, weakness, headaches, vomiting, and muscle pains [1]. Less commonly, patients may experience bleeding from the mouth or gastrointestinal tract, and the risk of death once infected is about one percent, frequently occurring within two weeks of symptom onset [1]. Among survivors, approximately one quarter experience hearing loss, which improves within three months in roughly half of these cases [1].

Epidemiology

Lassa virus is endemic in rodent populations in Sierra Leone, Nigeria, and other countries in West Africa, with spillover to humans occurring frequently and resulting in a viral haemorrhagic fever associated with a high case-fatality rate [2]. The 2018 outbreak was the largest Lassa fever outbreak recorded; it spread to 18 of Nigeria's states and resulted in 3,498 infections and 171 deaths, with Nigeria accounting for over half of the total regional cases and fatalities [1]. That year, Sierra Leone reported 129 infections and 12 deaths, with the outbreak especially severe in Kenema and Bo Districts, while Guinea experienced 98 cases and 8 fatalities and was among the least affected countries in the region [1]. Public-health authorities have highlighted concerns about more frequent outbreaks, the potential for further geographic expansion of Mastomys natalensis and other rodent reservoirs, and the emergence of novel LASV strains in densely populated West African settings [2].

Transmission

Lassa fever is usually spread to humans via contact with the urine or faeces of an infected multimammate mouse (Mastomys natalensis), after which person-to-person transmission can occur through direct contact [1].

Prevention

There is no approved vaccine for Lassa virus, making prevention dependent on isolation of infected individuals and reducing contact with reservoir rodents [1][2]. Recommended measures include storing food in sealed containers to limit rodent access and keeping cats to hunt vermin [1]. Community awareness initiatives promoting hygiene practices, early intervention measures, and stringent border screenings have been employed during outbreaks to limit further spread [1].

Coding Register
ICD-10
A96.2
ICD-11
1D61
Key Statistics
Total cases
1
Peak month
2026-01
Coverage
4 reporting countries · 2011-01-01 → 2026-09-01

Coverage

Reporting countries and regions

4 locations

Monthly patterns over time

Research Radar

Recent related research

View all research →

Literature links are provided for discovery and do not alter or validate the surveillance series above.

Data access

Page dataset index with source links and update metadata.

Rows925
Updated2026-09-01
Coverage
Partitions4
Source0 series · 0 observations
Official sourcesAuthority, cadence, notes7
China

China CDC Weekly

China

Source
MONTHLYweb

Monthly notifiable infectious disease reports published by China CDC.

China

National Disease Control and Prevention Administration

China

Source
MONTHLYweb

Official China public health bulletin and query portal.

China

PubMed

China

Source
MONTHLYweb

Biomedical literature discovery feed used as supplementary context.

Japan

JP NIID Weekly

Japan

Source
weeklyweb

Japan weekly infectious disease surveillance via NIID/JIHS.

South Korea

Korea KDCA EID

South Korea

Source
monthlyopen_api_or_portal_download

Korea KDCA notifiable infectious disease OpenAPI or portal/KOSIS downloads aggregated to national monthly notification counts.

United States

US CDC NNDSS

United States

Source
mixed_weekly_annualapi

CDC National Notifiable Diseases Surveillance System provisional data.

United States

US CDC NHSS HIV

United States

Source
mixed_weekly_annualapi

CDC NNDSS weekly data plus NHSS annual national HIV diagnoses

Partitioned public data

Choose a time range and format